(Food-Beverage-News.Com, July 20, 2018 ) The report "Flow Cytometry Market by Technology (Cell & Bead-based), Product & Services (Analyzer, Sorter, Reagents), Application (Research (Cell Analysis), Clinical (Cancer, HIV)), End User (Academia, Research Institute, Hospital) - Global Forecast to 2022", The global flow cytometry market is expected to reach USD 4.79 Billion by 2022 from USD 3.29 Billion in 2017, at a CAGR of 7.8%.
Browse 134 tables and 37 figures spread through 202 pages and in-depth TOC on "Flow Cytometry Market by Technology (Cell & Bead-based), Product & Services (Analyzer, Sorter, Reagents), Application (Research (Cell Analysis), Clinical (Cancer, HIV)), End User (Academia, Research Institute, Hospital) - Global Forecast to 2022"
Early buyers will receive 10% customization on reports. The major factors driving the growth of the flow cytometry market include the continuous technological advancements in the field of flow cytometry, increasing incidence and prevalence of target diseases (such as HIV/AIDS and cancer), growing adoption of flow cytometry in advanced research activities and clinical trials, and increasing availability of novel application-specific flow cytometry products.
The reagents and consumables held the largest share of the flow cytometry market by product in 2017 The flow cytometry market is segmented on the basis of products and services into reagents and consumables, instruments, services, software, and accessories. The reagents and consumables products segment is expected to command the largest share of the global flow cytometry market in 2017. Factors such as the development and commercialization of high-quality application-specific reagents and assays and continuous requirement of flow cytometry reagents by end users (due to the increasing number of flow cytometry-based research activities) are expected to drive the growth of the reagents and consumables market in the coming years. Academic and research institutes were the largest end users of flow cytometry products and services in 2017 By end user, the market is segmented into academic and research institutes, hospitals and clinical testing laboratories, and pharmaceutical and biotechnology companies. The academic and research institutes end-user segment is expected to account for the largest share of the flow cytometry market in 2017 due to the growing use of flow cytometry for research in cancer, stem cell, and HIV; increasing number of cancer and stem cell research projects across the globe; and increasing public-private funding for flow cytometry-based research.
North America dominated the flow cytometry market in 2017 Geographically, the market is segmented into North America (the US and Canada), Europe (Germany, the UK, France, and the Rest of Europe), Asia Pacific (Japan, China, India, and the Rest of APAC), and the Rest of the World. North America is expected to account for the largest share of the global flow cytometry market in 2017. Factors such as the continuous technological advancements in flow cytometry instruments, growing advanced cell-based research activities coupled with rising adoption of advanced flow cytometry techniques, high prevalence of HIV/AIDS and cancer, and increasing number of clinical trials for the development of treatment options for target diseases (such as cancer and immunological disorders).
The major players operating in the flow cytometry market include BD (US), Beckman Coulter (US), and Thermo Fisher Scientific (US), among others.
